Ef2: a new LY-3-linked light-chain marker expressed in normal mouse serum immunoglobulin by unknown
Ef2:  A  NEW  LY-3-LINKED  LIGHT-CHAIN  MARKER 
EXPRESSED  IN  NORMAL  MOUSE  SERUM 
IMMUNOGLOBULIN* 
B'L  DAVID M.  GIBSON:~ AND  SHEILA J.  MAcLEAN 
From the Dgpartement de Biochimie,  Universitl de Sherbrooke, Sherbrooke, Qugbec Canada, J1H 5N4 
Polymorphism  associated  with  mouse  immunoglobulin  kappa  chains  has  been 
detected by peptide mapping (1) and isoelectric focusing (IF) a of normal serum light 
chains (2) as well as by IF of the light chains of antiphosphoryl choline antibodies (3). 
All three markers have been found to share an identical strain distribution;  studies 
involving  Ly-2  ~,  3~-congenic  lines  (4),  as  well  as  the  AKXL  (5,  6)  and  NX8  (7) 
recombinant inbred lines (8) have established that the light-chain markers are closely 
linked  to  the  Ly-2  and  Ly-3  loci  on  Chromosome  6  coding  for  the  lymphocyte 
differentiation antigens Lyt-2 and Lyt-3 (9,  10).  Recent evidence suggesting that the 
structural  gene for C~ does not reside on Chromosome 6 has led to speculation  that 
the Ly-3-1inked, light-chain  V-region  loci  may be regulatory rather  than  structural 
(11). The possibility that the Ly-3 locus and light-chain loci may be one and the same 
locus has also been considered  (12). 
We report here a new light-chain IF marker (which we propose to call Ef2), showing 
a strain distribution different from the other light-chain markers and the Ly-3 marker. 
The  finding of the  Ef2  marker resulted  from the  analysis of normal  light-chain  IF 
spectra in a  large series of the inbred  mouse strains.  As reported earlier,  four light- 
chain  IF-banding patterns  are recognizable among the  inbred  strains  (13).  Careful 
analysis of the differences among the four banding patterns, however, indicated that 
they could  readily  be explained  by postulating  the  existence  of two  loci  with  two 
alleles at each locus. The first locus, Igk-Efl, has already been described in some detail 
(6). 
Materials and Methods 
Mice.  NZB/B1NJ mice were purchased as adults from The Jackson Laboratory, Bar Harbor, 
Maine; C58/J, BALB/eJ, and AKR/J mice were from our own colony and represent the 8- 
10th inbreeding generation since  they were obtained from The Jackson Laboratory in  1976. 
Serum from all inbred strains listed  in Table I was obtained from The Jackson Laboratory. 
B6.C3 FI animals carrying the hypodaetyly (Hd) mutation were a generous gift of Dr. P. Lane 
of the Jackson Laboratory. 
Isolation of Immunoglobulins.  Immunoglobulin was  purified  from normal  mouse serum by 
absorption onto protein A-Sepharose.  For routine light-chain analysis, 0.2 ml of normal mouse 
serum was used. 
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Reduction andAlkylation.  Reduction and alkylation was carried out using a two-step procedure 
as described  (2). In the initial  step, reduction was effected  by addition of 25  nmol of DTT 
followed 30 min later by 50 nmol of [ 1-a4C]iodoacetamide (Amersham Corp., Arlington Heights, 
Ill. 50 mCi/mmol). In the second  step, complete reduction and alkylation was carried out as 
described  (2). 
Chain Separation and IF of Light Chains.  Heavy and  light  chains were separated by urea- 
formate gel electrophoresis  as described (6). A guide strip was stained to localize the light-chain 
zone. The light-chain-containing zone was excised as a strip from the unstained part of the gel 
and transferred directly to the IF gel at the anode end. The IF gel contained 6.4 M urea and 
2% Bio-Lyte (Bio-Rad Laboratories, Richmond, Calif.), pH 3-10. The procedures for IF, fixing, 
and drying of the gels have been described  (6), 
Results 
Description of the Ef2 Marker.  The characteristics of the new marker are illustrated 
in Fig.  1, which shows the banding patterns of normal light chains of NZB/BINJ and 
BALB/cJ mice. The most striking difference between the two patterns is seen as the 
presence of two discrete bands (63 and 54) in the BALB/c patterns, although several 
other differences are also evident  (e.g., bands 5,  20, and 30).  It is interesting to note 
that  the two major bands affected (63 and 54)  differ by the characteristic  1-charge 
spacing (~0.25 pH U) exhibited by the homologues of typical myeloma light chains. 
This would suggest that the two bands may actually represent the same subgroup of 
light chain. In an attempt to characterize more precisely the identity of the band 63/ 
54  light  chains,  we  have screened  more  than  275  BALB/c  myeloma proteins  (14) 
using the IF procedure.  We have now identified a  total of seven BALB/c myeloma 
light chains which co-focus with bands 54 and 63 of the normal light-chain pattern. 
Several of these light chains  are illustrated  in Figs.  1 and 2.  In contrast  to the high 
incidence of band 63/54 light chains among the BALB/c myelomas (7 out of 277), we 
have not yet identified light chains co-focusing precisely with bands 54 and 63  in a 
screening  of  128  myelomas  derived  from  NZB  mice  (15).  This  suggests  that  the 
"subgroup" of light chains represented by bands 54 and 63, which is greatly reduced 
in normal NZB serum Ig, may also be underrepresented in the NZB myelomas. This 
would be consistent with the suggestion that normal immunoglobulin and myeloma 
immunoglobulins  both  represent  samplings  of sequences  from  the  same  V-region 
repertoire, namely, that expressed in the mature plasma cell compartment (16). 
Relationships Between Efl and Ef2 Markers.  The relationship  between the Ell  and 
Ef2 markers as they affect the normal light-chain IF profiles is illustrated  in Fig.  2. 
This figure includes examples of two individual  mice of each of the four recognized 
light-chain banding phenotypes. 
Close Linkage of the Efl and Ef2 Markers.  The strain distribution of the Ef2 marker 
(Table  I)  indicated  that  it  was  distinct  from  the  Ly-2  and  Ly-3  markers  because 
strains of the same Ly-2 and Ly-3 type (e.g., NZB/B1NJ and BALB/cJ)  (17)  differed 
with respect to the Ef2 marker (Figure  1). Linkage studies  (summarizEd in Table II) 
have  indicated  that  the  locus  controlling  the  Ef2-marker  light  chains  (which  we 
propose to call Igk-Ef2) is closely linked to Ly-3, because in a total of 95 testcross mice 
no  recombinants  have been  detected  between  the  Ef2  marker and  the  Ly-3-1inked 
marked Efl  (Fig. 3). 
Linkage of Igk-Ef2 to Hypodactyly (Hd).  We have investigated the segregation of the 
Ef2-1ight-chain marker with respect to a second Chromosome-6 marker, Hd (19).  The DAVID  M. GIBSON  AND  SHEILA J. MAcLEAN  1479 
FIG.  1.  Light-chain  IF  patterns  illustrating differences  controlled  by  Igk-Ef2.  Samples  (c-e) 
represent  normal light chains of pooled  (c) and individual (d, e) NZB/BINJ mice. Samples  (f-h) 
represent  normal light chains of individual (f, g) and pooled (h) BALB/c mice. Samples (a), (b), (i), 
and (j) correspond  to light chains of BALB/c myelomas FLOPC-I, FLOPC-21, TEPC (CAL 20)- 
119, and TEPC-821. These myeloma light chains, as well as the light chains of BALB/c myelomas 
TEPC (CAL 20)-105, TEPC-817, and TEPC-602, were found to co-focus precisely with the Ef2 
marker  light-chain bands 63  and  54.  Arrows  indicate major  differences  between  the  Igk-Ef2 a 
(BALB/c)  and Igk-Ef2 b (NZB)  types.  The band numbers are used  for reference  to  the text.  In 
certain instances,  improved resolution  has  revealed  additional bands (e.g., 8A) compared to the 
original numbering scheme (13). 
mutation,  a  semidominant  lethal,  arose  in  the  inbred strain  MYA  and  was  subse- 
quently outcrossed. It is currently maintained by crossing to B6.C3 F1 hybrid animals. 
The presence of the Hd mutation  in the heterozygous state is readily detected  as the 
absence or reduction in the first digit (hallux) of the hind foot. Hd/+  animals showed 
a  light-chain banding phenotype identical to  that  of the parental  strains C57BL/6J 
and  C3H/HeJ,  indicating  that  the  Hd  mutation  itself  did  not  affect  light-chain 1480  Ef2:  A  NEW  GENETIC  MARKER  OF  MOUSE  LIGHT  CHAINS 
Fie.  2.  Normal light-chain IF spectra showing the relationship between the Efl and Ef2 markers. 
Sample (a) represents the light chain of the BALB/c myeloma protein FLOPC-21. Samples (b) and 
(c) are light chains from two individual BALB/c mice; samples (d) and (e):  two individual AKR/ 
J;  samples  (f)  and  (g):  two  individual  C58/J;  (h)  and  (i):  two  individual  NZB/BINJ.  Arrows 
indicate major differences controlled by the lgk-Efl and lgk-Ef2 loci. The pattern represents a  1-wk 
autoradiogram of the dried gel. 
expression.  Because  both  C57BL/6J  and  C3H/HeJ  mice possess the Igk-Ef2~-light - 
chain allele, linkage of Igk-Ef2 and Hd could be tested by crossing (B6xC58/J)F1-Hd/ 
+  hybrid mice back to C58/J.  In 37 out of 37 backcross animals examined we have 
found complete concordance between the presence of Hd-  and the Ef2-marker light- 
chain  bands  (bands  54/63).  This  would  indicate  that  the  Igk-Ef2  and  Hd loci  are 
separated by <9.5  map units  (percent recombination)  at  the 95% confidence limits. 
Discussion 
We have interpreted differences observed in the IF patterns of normal light chains 
of inbred mouse strains in terms of a genetic model involving two loci with two alleles DAVID  M.  GIBSON  AND  SHEILA  J.  MAcLEAN 
TABLE  I 
Strain Distribution of Alleles at Igk-Efl, Igk-Ef2, Ly-2, and Ly-3 Loci* 
1481 
Strain  Igk-Efl  Igk-Ef2  Ly-2  Ly-3 
AKR/J, PL/J, RF/J 
c58/j 
A/J,  BALB/cJ,  BUB/BnJ,  C57BL/KsJ,  C57BL/6J, 
C57BL/10J, C57BR/cdJ, C57L/J, CBA/H-T6J,  129/ 
J, LP/J, ST/b  J, SWR/J, SJL/J 
CBA/J, C3H/HeJ, DBA/1J, DBA/2J, SM/J 
A/He  J,  A/WySn,  A.BY/Sn,  CBA/CaJ,  C57BL/10Sn, 
LG/J, RIII/2J 
BOP/J, CE/J, I/LnJ 
NZB/BINJ 
P/J 
a  a  a  a 
a  b  a  a 
b  a  b  b 
b  a  a  b 
b  a  ?  b 
b  b  a  b 
b  b  b  b 
b  b  ?  b 
* Ly-2 and Ly-3 are summarized from references 10,  18, 6, and 17. 
TABLE  II 
Evidence for Linkage of lgk-Efl and Zgk-Ef2 
tgk-Efl  lgk-Ef2 
Band  No.  Band  No. 
Allele  Allele 
25/  58  60  61  66  54  63 
26 
Parental, FI hybrid strains 
BALB/cJ  b  +  -  +  a  +  + 
C58/J  a  -  +  -  +  +  b 
((258/,]  ×  BALB/cJ)F~  a/b  +  +  +  +  +  a/b  +  + 
NZB/BINJ  b  +  -  +  b 
AKR/J  a  -  +  -  +  +  a  +  + 
(AKR/J  ×  NZB/BINJ)F~  a/b  +  +  +  +  +  a/b  +  + 
Number 
of ani- 
mals* 
32 
28 
Experimental cross I:  (C58/J  x  BALB/cJ)FI  x  NZB/BINJ 
Nonrecombinant  b/b  +  -  +  a/b  +  + 
Phenotypes  a/b  +  +  +  +  +  b/b 
Recombinant  b/b  +  -  +  b/b  0 
Phenotypes  a/b  +  +  +  +  +  a/b  +  +  0 
Experimental cross II:  (AKR/J  X  NZB/BINJ)Fa  ×  NZB/BINJ 
Nonrecombinant  a/b  +  +  +  +  +  a/b  +  +  19 
Phenotypes  b/b  +  -  +  b/b  16 
Recombinant  a/b  +  +  +  +  +  b/b  0 
Phenotypes  b/b  +  -  +  a/b  +  +  0 
* No recombinants in 95 instances indicates that the two markers are separated by <3.9 map units (percent 
recombination) at the 95% confidence limits (chi-square method). 
at  each  locus.  The  ~odel  is  attractive  because  it  allows  a  simple  explanation  of the 
four  light-chain  banding  phenotypes  so  far  distinguished.  The  four  phenotypes,  as 
observed  in  the  prototype  strains  BALB/c,  AKR,  NZB,  and  C58,  represent  the  four 
possible  combinations  of the  two  alleles  at  each  locus.  The  two  loci  determining  the 1482  Ef2:  A  NEW  GENETIC  MARKER OF  MOUSE  LIGHT CHAINS 
FIG.  3.  Normal  light-chain  IF  spectra  of parental,  F1  hybrid,  and  individual  testcross  mice 
(experimental cross I, Table II). The parental strains  BALB/c J, C58/J, and NZB/BINJ; and the 
(BALB/cJ ×  C58/J)Fl-hybrid patterns are samples  (e), (f),  (h), and (g), respectively.  Samples (a- 
d)  and  (i-l)  represent  light  chains  from  individual  testcross  animals.  Arrows  indicate  bands 
controlled by the lgk-Efl and Igk-Ef2  loci. Band 66 in this  gel is not resolved  completely from a 
minor band present in both BALB/c and C58 patterns; it thus appears as an incomplete absence in 
the testcross patterns.  In gels where complete resolution  of band 66 is obtained, complete absence 
is observed  in the negative patterns.  Clear differences  are noted in the case of the better-resolved 
Efl-marker bands 58 and 61, and in Ef2-marker bands 63 and 54. Sample (m) represents  the light 
chain obtained from 1/~1 of reduced and alkylated ascites fluid from the BALB/c myeloma LPC-1. 
banding  differences have been designated lgk-Efl and lgk-Ef2 in accordance  with the 
new guidelines proposed by Green  (20).  Each of the loci seems to affect the expression 
of a  distinct  set  of bands  in  the  normal  light-chain  IF  profiles.  The  differences  in 
several cases appear  to  involve the complete disappearance  of given bands  (e.g.,  Efl 
marker  bands  61  and  66  and  Ef2  marker  bands  54  and  63).  In  the case of several  of 
the  minor bands,  however  (e.g.,  Ef2  bands  5,  8,  and  20),  it  is  not  clear whether  the 
differences  observed  may  be  more  of  a  quantitative  nature.  At  least  some  of  the DAVID M. GIBSON AND SHEILA J.  MAcLEAN  1483 
difficulty in deciding between quantitative and qualitative differences is due to the 
limitations of resolution. If two components are not completely resolved, the disap- 
pearance of one component would not cause the disappearance of an entire band, but 
only a reduction in its intensity. 
Results indicate that Igk-Ef2 is closely linked to Igk-Efl  and hence to Ly-3 because 
in a total of 95 testcross mice no recombinants have been found. The Ef2 marker was 
also found to map close to Hd, a second Chromosome-6 marker investigated. Because 
no recombination has yet been demonstrated  between Igk-Efl  and Igk-Ef2,  formal 
proof of the second locus is lacking. We feel that  the alternative explanation of the 
results, namely, that the patterns are controlled by a single regulatory locus with four 
alleles,  is  less  satisfactory  as  the  differences  are  clearly  additive  in  the  different 
phenotypes  (e.g., AKR  pattern  =  C58 pattern  +  bands  54  and  63;  and  BALB/c 
pattern  =  NZB pattern  +  bands 54 and 63). An additional argument favoring the 
two-locus model is that  in Fa hybrids of the type (BALB/c  X  C58)Fa or  (AKR  X 
NZB)F1, one observes the products of three alleles; bands 66, 61, and 58 (Efla); bands 
25/26 and 60 (Eflb);  and bands 63 and 54 (Ef2  a)  (Table II and Fig. 3). 
Perhaps the most  interesting aspect of the normal light-chain IF markers is that 
they seem to involve discrete groups of light chains. It is tempting to speculate that 
the bands observed in the normal light-chain IF profiles correspond to light chains 
belonging to the same V-region subgroup and, hence, that the differences represent 
the  absence of certain  V-region  subgroups  in  some strains  of mice.  Although  this 
interpretation  seems  an  oversimplification, we  have,  so  far,  no  evidence that  it  is 
incorrect and,  indeed,  much data support  it.  A  survey of the  focusing behavior of 
BALB/c and NZB  light chains of known amino acid sequence indicates that  well- 
defined subgroups of light chains such as ~k-1 (21) or V~-21 A, B, C, D, E, and F  (22, 
23)  behave  precisely according to expectation;  i.e., those differing by only neutral 
substitutions co-focus with each other and correspond to prominent bands present in 
the normal light-chain IF profiles.  2 In the case of the ~-1  subgroup, for example, all 
proteins so far examined co-focus with normal light-chain band 22. The supposition 
that band 22 in the normal pattern actually represents the ~-1 subgroup is supported 
by the finding that band 22 is greatly reduced in SJL light-chain patterns, consistent 
with the results of Geckeler et al., (24)  who have reported a 50-fold reduction in X-1 
light chains in SJL serum immunoglobulin. 
The  interpretaffbn  of normal  light-chain  IF  bands  as  representing  light  chains 
sharing the same V-region subgroup would lead to the prediction that  the BALB/c 
myeloma light chains corresponding to the Ef2-marker bands (e.g., FLOPC-1, TEPC- 
817, etc.; Figs.  1 and 2) will define the major subgroup of light chains controlled by 
the Igk-Ef2 locus. One would  thus expect to  find this subgroup  greatly reduced or 
absent in strains bearing the Igk-Ef2 b allele. Amino acid sequencing of a  number of 
these proteins is currently under way in this laboratory and the results should provide 
a precise definition of the nature of the Ef2 marker. 
In considering candidates for a genetic mechanism operative at the level of the V- 
region subgroup, one is forced to consider mechanisms operating close to the V-region 
repertoire itself. Such mechanisms could include differences in the content of V~ genes 
or in the factors controlling V,-gene expression (e.g., at  the level of V-C joining or 
subsequent processing [25]).  Regulatory influences affecting light-chain expression at 
2  Gibson et al. Manuscript in preparation. 1484  Ef2:  A  NEW  GENETIC  MARKER  OF  MOUSE  LIGHT CHAINS 
the level of clonal proliferation would not  be expected to select for given V-region 
subgroups,  because the V-region subgroup  itself may be of little functional signifi- 
cance. This follows mainly from the assumption that light chains of a given subgroup 
may participate in a  wide variety of functional combinations with heavy chains of 
different Vn sequence and CH class. 
We feel that the simplest working hypothesis to explain the present results is still 
that the differences observed are due to differences in the V~-gene repertoire (2). This 
interpretation has several important implications.  Firstly, it suggests that  there may 
be relatively few V~-structural genes (e.g.,  of the order of 100) coding for the bulk of 
normal  serum  immunoglobulin  light  chains,  because  the  discrete  differences  we 
observe represent about  1% of the light-chain pattern.  This conclusion is not  com- 
pletely  out  of line  with  recent  estimates  based  on  saturation  hybridization  that 
indicate  that  there  may be  of the  order  of 300  V~-structural  genes  in  the  mouse 
genome (26). In both instances, a significant role for somatic diversif.'ation is implied. 
A  second implication of the structural  gene hypothesis is that  the genes coding for 
mouse V~ sequences must  reside on Chromosome 6. The Chromosome-6 location of 
the  V~-structural  genes,  however,  is  currently  a  subject  of controversy,  because 
conflicting reports  have  appeared  (11,  27).  Interpretation  of the  results  as  due  to 
differences in V~-structural genes also has implications for the recently proposed gene 
rearrangement  model  (23).  In  this  model,  each  V~  gene  (coding  for  amino  acid 
positions  1-98)  (28)  may integrate with  any one of several J  segments  (coding for 
amino acid positions 99-112)  (29).  Each V~ gene would thus give rise to a set of gene 
products  representing  the  V  sequence  in  combination  with  different J  segments. 
Examination of the available sequence data indicates that the majority of amino acid 
sequence differences in the J  segment are neutral in character and would therefore 
not  affect  the  IF  position  of the  light  chain.  At  least  one J  sequence  (e.g.,  that 
associated with the NZB light chain 2413), does differ by charge, however, and this 
would be expected to shift the position of the light chain anodally by 4 charge U  (23). 
It  is  interesting to note that  although  the  major difference determined  by Igk-Ef2 
involves  bands  63  and  54,  other  linked  differences  (e.g.,  bands  20,  30,  etc.)  are 
observed ~  3 and 4 charge U  anodal to the major difference. Close analysis of the 
differences, has indicated that  the spacing between bands 63 and  54, and  the more 
anodal  pair,  30 and  20,  is  too large to be explained by precise 3  and  4  charge U 
differences. We therefore feel it is unlikely that the differences in the region of band 
30  can  be simply explained  as  due  to  band  63  light  chains  with  a  more acidic J 
segment. Further analysis of the linked differences controlled by the Igk-Efl and Igk- 
El2 loci, however, may well  be informative for establishing the extent to which j- 
region differences affect the normal light-chain IF patterns. 
Interpretation of the present results is also possible by postulating an Ly-3-1inked 
regulatory locus, or by supposing that the Ly-3 locus itself governs the expression of 
light  chains,  but  the  regulatory  interpretation  becomes  more  unwieldy  with  the 
demonstration of additional V-region loci. 
Summary 
A new light-chain marker has been detected in normal mouse serum immunoglob- 
ulin light chains by gel isoelectric focusing. The marker (Ef2) involves the presence of 
two  major and  several  minor bands  in  the  normal  light-chain  IF profiles.  Strains DAVID  M.  GIBSON  AND SHEILA J.  MAcLEAN  1485 
expressing  the  marker  IF bands  are  designated  Igk-Ef2 ~, whereas  those  lacking  the 
bands are Igk-Ef2 b. The majority of inbred  strains are Igk-Ef2".  Strains  found to be 
Igk-Ef2 b are NZB/B1NJ, BDP/J, C58/J, I/LnJ, CE/J, and P/J. The strain distribution 
of the alleles differs from the distribution of alleles at the Ly-2 and Ly-3 loci, suggesting 
the new marker may represent  a separate locus. Genetic studies have shown that Igk- 
Ef2 locus is closely linked to Igk-Efl  and Hd loci on Chromosome 6, indicating tlaat it 
is also closely linked  to Ly-3. The relative importance of the bands controlled by the 
Igk-Ef2  locus suggests that the entire normal light-chain pool could be controlled by 
as few as  100 such loci. 
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